Clinical trial
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating…
NCT00017368 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00017368 |
|---|---|
| Title | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma |
| Official title | A Pilot Study Of Tandem High Dose Chemotherapy With Stem Cell Rescue Following Induction Therapy In Children With High Risk Neuroblastoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, sargramostim, carboplatin, cisplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, etoposide phosphate, ifosfamide, isotretinoin and 6 more |
| Enrollment | 42 |
| Start date | Apr 1, 2001 |
| Primary completion | Sep 1, 2005 |
| Completion | Jan 1, 2012 |
| First posted | Oct 9, 2003 |
| Last update posted | Feb 13, 2014 |
| Countries | Australia, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: